GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Equity-to-Asset

Orion Pharma (DHA:ORIONPHARM) Equity-to-Asset : 0.42 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Orion Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was BDT21,765 Mil. Orion Pharma's Total Assets for the quarter that ended in Mar. 2024 was BDT52,320 Mil. Therefore, Orion Pharma's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.42.

The historical rank and industry rank for Orion Pharma's Equity-to-Asset or its related term are showing as below:

DHA:ORIONPHARM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.38   Med: 0.55   Max: 0.62
Current: 0.42

During the past 11 years, the highest Equity to Asset Ratio of Orion Pharma was 0.62. The lowest was 0.38. And the median was 0.55.

DHA:ORIONPHARM's Equity-to-Asset is ranked better than
53.51% of 441 companies
in the Utilities - Independent Power Producers industry
Industry Median: 0.4 vs DHA:ORIONPHARM: 0.42

Orion Pharma Equity-to-Asset Historical Data

The historical data trend for Orion Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Equity-to-Asset Chart

Orion Pharma Annual Data
Trend Dec13 Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 0.49 0.44 0.40 0.39

Orion Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.39 0.38 0.39 0.42

Competitive Comparison of Orion Pharma's Equity-to-Asset

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's Equity-to-Asset Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Equity-to-Asset falls into.



Orion Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Orion Pharma's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )=Total Stockholders Equity/Total Assets
=20824.432/52939.683
=0.39

Orion Pharma's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=21764.65/52319.604
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Pharma  (DHA:ORIONPHARM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Orion Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma (DHA:ORIONPHARM) Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma (DHA:ORIONPHARM) Headlines

No Headlines